1. Home
  2. VERX vs LQDA Comparison

VERX vs LQDA Comparison

Compare VERX & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertex Inc.

VERX

Vertex Inc.

HOLD

Current Price

$19.93

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$35.45

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERX
LQDA
Founded
1978
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.1B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
VERX
LQDA
Price
$19.93
$35.45
Analyst Decision
Buy
Strong Buy
Analyst Count
16
10
Target Price
$35.73
$37.40
AVG Volume (30 Days)
1.1M
1.5M
Earning Date
02-26-2026
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$732,189,000.00
$69,216,000.00
Revenue This Year
$14.49
$994.17
Revenue Next Year
$10.82
$169.25
P/E Ratio
N/A
N/A
Revenue Growth
13.83
343.41
52 Week Low
$18.54
$11.26
52 Week High
$60.71
$38.16

Technical Indicators

Market Signals
Indicator
VERX
LQDA
Relative Strength Index (RSI) 48.55 59.65
Support Level $18.93 $29.30
Resistance Level $20.40 $35.20
Average True Range (ATR) 0.59 2.26
MACD 0.04 -0.36
Stochastic Oscillator 56.50 71.95

Price Performance

Historical Comparison
VERX
LQDA

About VERX Vertex Inc.

Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting among others. The company derives revenue from software subscriptions.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: